Taken together, for the first time, the present study demonstrated that the enhanced CIK cells activated by IL-2 and IL-15 exerted stronger antitumor effects on RCC in vitro and in vivo through IFN-γ and perforin/granzyme-induced apoptosis. This evidence concerns the gene PRF1 and renal cell carcinoma.